Skip to content
healthcare.dev
Get a free key

Breo Ellipta

NDC 0173-0916, fluticasone furoate and vilanterol trifenatate, powder, from GlaxoSmithKline LLC.

Product NDC
0173-0916
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204275
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0916 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUTICASONE FUROATE50 ug/1
  • VILANTEROL TRIFENATATE25 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0173-0916-10001730916101 TRAY in 1 CARTON (0173-0916-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/96428df1-ea05-431a-98d3-1ec2c4b63878

  • NADAC price for package 00173091610

    GET /v1/drugs/nadac/00173091610

Use it

Look up 0173-0916 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0916 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0916. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.